ASPIRE will save tens of thousands of lives by implementing a scalable and affordable integrated cervical cancer screening program that uses a novel technology developed specifically for cervical cancer screening in resource limited countries.

ASPIRE’s approach using HPV DNA technology focuses on five areas:

  1. Introduction of self collection of vaginal specimens for Human Papillomavirus (HPV) testing at three sites
  2. See-and-Treat intervention on site (at the local health centre) for precancerous lesions
  3. Referral to hospital for advance cancer treatment
  4. Capacity and knowledge strengthening through colposcopy training for local physicians
  5. Information, communication and education on cervical cancer prevention and treatment


The ASPIRE team generates sound research evidence as the foundation for sustainable program implementation. Project goals are driven by local leaders in Uganda and actively engage the local community to ensure optimal acceptability and to maximize health benefits. The ASPIRE Process address the whole spectrum of care through six practical steps: Educate, Mobilize, Collect, Test, Treat, and GrowSome of the unique features of the ASPIRE model include:

  • The utilization of HPV self collection where women collect their own samples in their home
  • Testing, diagnosis and treatment can be trained and performed by existing health care professionals such as nurses, midwives and lab technicians
  • Low maintenance technology that minimizes resource demands
  • It is less expensive than traditional screening technology while still being highly effective